MMSI Merit Medical Systems Inc.

Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference

Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference

SOUTH JORDAN, Utah, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference.

On Thursday, February 25, at 2:20 p.m. ET, Fred P. Lampropoulos, President and Chief Executive Officer of Merit, and Raul Parra, Merit’s Chief Financial Officer, will present at the 2021 SVB Leerink Global Healthcare Conference, which is being held virtually. They will also host virtual one-on-one meetings throughout the day.

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

Contacts:

 
  
PR/Media Inquiries:

Investor Inquiries:

Teresa JohnsonMike Piccinino, CFA, IRC
Merit MedicalWestwicke - ICR



EN
10/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Merit Medical Systems Inc.

 PRESS RELEASE

Merit Medical Systems to Announce Third Quarter 2025 Results on Octobe...

Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025 SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same day (Thursday, October 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). ...

 PRESS RELEASE

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with...

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SOUTH JORDAN, Utah, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced a significant milestone for breast cancer treatment: SCOUT® Radar Localization use has reached 750,000 patients worldwide.1 This global achievement coincides with Breast Cancer Awareness Month, a time dedicated to educating the public about the ...

 PRESS RELEASE

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Ar...

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results. SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolisation (GAE) to treat patients with knee osteoarthritis (OA). The...

 PRESS RELEASE

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North Americ...

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE).The first WRAP North America patient was enrolled at Bluff City Vascular, an interventional nephrology and vascular access center in Memphis, TN. SOUTH JORDAN, Utah, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the successful enroll...

 PRESS RELEASE

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer ...

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion SOUTH JORDAN, Utah, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the US commercial release of the Prelude Wave™ Hydrophilic Sheath Introducer with SnapFix™ Securement Technology. The Prelude Wave is the latest innovation in Meri...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch